Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadroparin accumulation in renal insufficiency assessed by anti-Xa levels
NL-OMON26211Not yet recruiting
- Sponsor
- Erasmus MC Rotterdam
- Start
- May 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of nadroparin in venous thromboembolism (VTE), sponsored by Erasmus MC Rotterdam. Planned start May 2011; status: not yet recruiting.
02
Drugs
nadroparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NL-OMON26211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26211.